Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports
New Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline the transition from research to clinical environments
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
Zydus’ Sitagliptin base contains the active moiety Sitagliptin in a different form than used in the branded reference product, Januvia (Sitagliptin Phosphate)
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
The company will manufacture the products at its US FDA approved oral dosage facility at Goa in India
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
The approval allows it to market its products in the country
Subscribe To Our Newsletter & Stay Updated
